Pricing Log in Create free account
Saturday 17 October 2026 Export BMY’s income statement to Excel — free account

Bristol Myers Squibb Company

BMY Healthcare Drug Manufacturers General

Bristol Myers Squibb Company’s revenue for fiscal 2025 (year ended December 2025) was $48.2 billion, roughly unchanged from fiscal 2024. In the quarter to June 2026, revenue grew 5.74%, EPS grew 153.1%, free cash flow fell 13.2% and total debt fell 12.3%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years.

59.71 0.86 −1.42%
Market cap
$123.7B
P/E
13.2×
Fwd P/E
11.2×
Dividend yield
4.22%
F-score
8/9
Altman Z
2.14
Beneish M
−2.69
Dividend safety
63/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Bristol Myers Squibb Company (BMY) Current ratio

Alert me on Current ratio

Bristol Myers Squibb Company's current ratio at the end of the quarter to 30 June 2026 was 1.5×, up 0.3× from fiscal 2025 (1.3×). Over the past ten years it has ranged from 1.2× (fiscal 2022) to 1.7× (fiscal 2018); the current reading is higher than 27% of that period. That is above the Drug Manufacturers General industry median of 1.3× and below the Healthcare sector median of 3.0×.

Current ratio, annual

Embed this chart

Annual newest first

Period Current ratio Change
FY2025 1.3× 0.20%
FY2024 1.3× (12.23%)
FY2023 1.4× 14.54%
FY2022 1.2× (18.09%)
FY2021 1.5× (3.88%)
FY2020 1.6× (1.33%)
FY2019 1.6× (3.55%)
FY2018 1.7× 7.05%
FY2017 1.6× 0.21%
FY2016 1.6× 19.32%

Quarterly newest first

Period Current ratio Change
Jun 2026 1.5× 7.84%
Mar 2026 1.4× 13.15%
Dec 2025 1.3× (0.88%)
Sep 2025 1.3× 4.93%
42 more quarters

Against its own ten years

Low 1.2× High 1.7×
Ten-year median 1.5×
Current reading's percentile 27

Current ratio against peers

Company Current ratio
BMY Bristol Myers Squibb Company 1.5×
AMGN Amgen Inc. compare 1.4×
PFE Pfizer Inc. compare 1.3×
GILD Gilead Sciences, Inc. compare 1.3×
SNY Sanofi compare 1.0×
AZN AstraZeneca PLC compare 0.9×
NVO Novo Nordisk A/S compare 0.9×
NVS Novartis AG compare 0.9×
GSK GSK PLC Sponsored ADR compare 0.8×
Drug Manufacturers General industry median 1.3×
Healthcare sector median 3.0×
Market median 1.6×

What Current ratio is

Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.

Current Assets (Total) ÷ Current Liabilities (Total)

The full definition of Current ratio →

More on BMY